Stranica 1 iz 29 rezultatima
FIELD OF INVENTION
The present invention relates to the treatment of pathologies and diseases that are inflammatory in nature. The treatment is practiced by the administration of des-aspartate-angiotensin I or its derivatives to a subject in need of such a treatment. The present invention further
FIELD OF INVENTION
The present invention relates to the treatment of pathologies and diseases that are inflammatory in nature. The treatment is practiced by the administration of des-aspartate-angiotensin I or its derivatives to a subject in need of such a treatment. The present invention further
FIELD OF THE INVENTION
The present invention provides compositions and methods for treating and preventing inflammatory bowel disease and other gastrointestinal disorders (e.g., mucositis, radiation induced enteritis, and short bowel syndrome). In particular, the present invention provides methods
FIELD OF THE INVENTION
This invention relates generally to compounds that are useful in the prevention and amelioration of signs and symptoms associated with inflammatory pain. More particularly, the present invention relates to the use of angiotensin II receptor 2 (AT.sub.2 receptor) antagonists
PRIORITY DATA AND INCORPORATION BY REFERENCE
This is a National Stage application under 35 U.S.C. 371 of International Application No. PCT/AU2007/000339, filed Mar. 20, 2007, which claims the benefit of priority to AU Application No. 2006901413 filed Mar. 20, 2006, the entireties of which are hereby
FIELD OF THE INVENTION
The present invention provides compositions and methods for treating inflammatory conditions (e.g., of the bowel). In particular, the present invention provides methods of treating (e.g., therapeutically and/or prophylactically treating) inflammatory conditions (e.g., of the
This application is a U.S. national stage of International Application No. PCT/JP2003/013851 filed Oct. 29, 2003.
TECHNICAL FIELD
This application relates to the invention of angiotensin-converting enzyme containing medicine. In detail, the invention of this application relates to a medicine that is
This application is a U.S. national Phase filing of International Serial No. PCT/IB2016/050122 filed Jan. 12, 2016, and claims priority to Australian provisional application No. 2015900077 filed Jan. 13, 2015, and Australian provisional application No. 2015902922 filed Jul. 23, 2015, the contents of
FIELD OF THE INVENTION
This invention relates to novel heteroaryl non-peptidic compounds that mimic the heptapeptide angiotensin (1-7) [Ang(1-7)] and act as agonists of the Mas receptor, especially in a selective manner. The invention further relates to methods of using such compounds as therapeutic
FIELD OF THE INVENTION
This invention relates to novel heteroaryl non-peptidic compounds that mimic the heptapeptide angiotensin (1-7) [Ang(1-7)] and act as agonists of the Mas receptor, especially in a selective manner. The invention further relates to methods of using such compounds as therapeutic
FIELD OF THE INVENTION
This invention relates to novel heteroaryl non-peptidic compounds that mimic the heptapeptide angiotensin (1-7) [Ang(1-7)] and act as agonists of the Mas receptor, especially in a selective manner. The invention further relates to methods of using such compounds as therapeutic
BACKGROUND OF INVENTION
It is currently believed that the diseases known as "autoimmune" diseases are caused by the body's immune system attacking the body itself. But I have discovered that these so-called "autoimmune" diseases are actually caused by stealthy intra-cellular bacteria. I have
FIELD OF INVENTION
The present invention relates to the treatment of pathologies and diseases that are inflammatory in nature. The treatment is practiced by the administration of des-aspartate-angiotensin I or its derivatives to a subject in need of such a treatment. The present invention further
REFERENCE TO A "SEQUENCE LISTING," A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED AS AN ASCII TEXT FILE
The present application contains a Sequence Listing written in file 056777-000330US-0967318_SequenceListing.txt created on May 26, 2016, 6,717 bytes, machine format IBM-PC, MS-Windows
FIELD OF THE INVENTION
The present invention relates to the use of vincamine derivatives for treating or preventing an inflammatory condition, and pharmaceutical compositions useful for practicing these therapeutic or preventative treatments.
BACKGROUND OF THE INVENTION
Inflammation is a hallmark of